Risk-reducing mastectomy in BRCA1/2 mutation carriers: Factors influencing uptake and timing

Maturitas

Volumn 77, Issue 2, 2014, Pages 180-184

  Van Driel, Catheleine M ^a   Eltahir, Yassir ^a   De Vries, Jakob ^a   Jaspers, Jan P ^a   Oosterwijk, Jan C ^a   Mourits, Marian J ^a   De Bock, Geertruida H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Breast neoplasms prevention control; Genes, BRCA1; Genes, BRCA2; Mastectomy; Risk reduction behavior; Time factors

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER RISK; DNA TEST; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; PARTIAL MASTECTOMY; PROSPECTIVE STUDY; RISK REDUCING MASTECTOMY; RISK REDUCTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS/PREVENTION & CONTROL; GENES, BRCA1; GENES, BRCA2; MASTECTOMY; RISK REDUCTION BEHAVIOR; TIME FACTORS;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MASTECTOMY; MIDDLE AGED; RISK REDUCTION BEHAVIOR; TIME FACTORS;

EID: 84893043379     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.10.017     Document Type: Article

References (23)

1. A. Antoniou, P.D. Pharoah, and S. Narod et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 2003 1117 1130
2. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 11 2007 1329 1333
3. D.M. van der Kolk, G.H. de Bock, and B.K. Leegte et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age Breast Cancer Res Treat 124 3 2010 643 651
4. N. Mavaddat, S. Peock, and D. Frost et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE J Natl Cancer Inst 29 2013
5. M.S. van Roosmalen, P.F. Stalmeier, and L.C. Verhoef et al. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers J Clin Oncol 22 16 2004 3293 3301
6. S.L. Spear, M.E. Carter, and K. Schwarz Prophylactic mastectomy: indications, options, and reconstructive alternatives Plast Reconstr Surg 115 3 2005 891 909
7. T.R. Rebbeck, T. Friebel, and H.T. Lynch et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol 22 6 2004 1055 1062
8. J.P. Gopie, M.A. Mureau, and C. Seynaeve et al. Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer Fam Cancer 2012
9. A.F. Howard, L.G. Balneaves, and J.L. Bottorff Women's decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review J Genet Couns 18 6 2009 578 597
10. G.H. De Bock, J.W. Hesselink, and C. Roorda et al. Model of care for women at increased risk of breast and ovarian cancer Maturitas 71 1 2012 3 5
11. I. Unic, L.C. Verhoef, P.F. Stalmeier, and W.A. van Daal Prophylactic mastectomy or screening in women suspected to have the BRCA1/2 mutation: a prospective pilot study of women's treatment choices and medical and decision-analytic recommendations Med Decis Making 20 3 2000 251 262
12. L.N. Lodder, P.G. Frets, and R.W. Trijsburg et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery) Breast Cancer Res Treat 73 2 2002 97 112
13. S. van Dijk, M.S. van Roosmalen, W. Otten, and P.F. Stalmeier Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret J Clin Oncol 26 14 2008 2358 2363
14. J.A. Ray, L.J. Loescher, and M. Brewer Risk-reduction surgery decisions in high-risk women seen for genetic counseling J Genet Couns 14 6 2005 473 484
15. S. van Dijk, W. Otten, and M.W. Zoeteweij et al. Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment Br J Cancer 88 11 2003 1675 1681
16. K.A. Metcalfe, W.D. Foulkes, and C. Kim-Sing et al. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation Clin Genet 73 5 2008 474 479
17. T.A. King, R. Sakr, and S. Patil et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy J Clin Oncol 29 16 2011 2158 2164
18. M. Yi, K.K. Hunt, and B.K. Arun et al. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy Cancer Prev Res (Phila) 3 8 2010 1026 1034
19. L. Scheuer, N. Kauff, and M. Robson et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 5 2002 1260 1268
20. M.S. Beattie, B. Crawford, F. Lin, E. Vittinghoff, and J. Ziegler Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers Genet Test Mol Biomarkers 13 1 2009 51 56
21. K.A. Metcalfe, J. Lubinski, and P. Ghadirian et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group J Clin Oncol 26 7 2008 1093 1097
22. D. Schrag, K.M. Kuntz, J.E. Garber, and J.C. Weeks Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations N Engl J Med 336 20 1997 1465 1471
23. S. van Dooren, C. Seynaeve, and A.J. Rijnsburger et al. The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer Breast Cancer Res Treat 89 1 2005 75 80